Skip to main content

Table 4 Separate associations between hospital quality system development and outcomes for patient safety themes

From: The association between quality system development stage and the implementation of process-level patient safety themes in Dutch hospitals: an observational study

  Model 1
Quality system (overall)
1: Policy and strategy 2: Human resource management 3: Patient involvement 4: Practice guidelines 5: Systematic quality improvement
Outcome Estimate (SE) R2 Estimate (SE) R2 Estimate (SE) R2 Estimate (SE) R2 Estimate (SE) R2 Estimate (SE) R2
Time-out procedure −1.89 (0.82) 32.3 − 1.33 (0.66) 25.4 − 1.25 (0.89) 11.4 −0.16 (0.38) 0.9 −1.08 (0.74) 13.7 −0.57 (0.37) 14.7
 - Check patient −2.49 (1.13) 43.5 −1.65 (0.88) 36.2 −0.73 (0.40) 36.0 0.19 (0.51) 6.1
 - Check procedure −2.61 (1.37) 18.3 −1.46 (1.06) 9.6 −1.78 (1.48) 5.2 −0.18 (0.58) −1.2 −1.02 (1.13) 3.3 −1.02 (0.55) 16.8
 - Check side/site −0.96 (0.49) 40.8 −0.32 (0.44) 8.8 −0.40 (0.54) 8.8 −0.59 (0.14) 8.5 0.09 (0.46) −0.5 −0.02 (0.23) 1.0
 - Focus during TOP −0.75 (0.62) 8.8 −0.45 (0.50) 4.8 −0.28 (0.61) −0.1 − 0.39 (0.24) 15.8 − 0.08 (0.53) −1.9 −0.02 (0.27) −1.7
Contrast- induced nephropathy 0.86 (0.68) 0.11 0.29 (0.44)** 14.0 −0.08 (0.63) −0.9 0.55 (0.25)* 30.8 −0.11 (0.45) −1.7 −0.17 (0.29) 2.2
Pain process indicator 100% 0.09 (0.98) −0.5 −0.55 (0.75) 2.3 0.41 (0.89) 0.1 0.28 (0.37) 7.3 −0.66 (0.62) 5.8 0.12 (0.40) −0.2
Medication reconciliation on admission 0.64 (1.40) −1.3 0.53 (0.99) −0.9 0.42 (1.06) −5.5 0.97 (0.76) 8.4 −0.41 (1.00) −3.8 −0.13 (0.67) −7.5
Medication reconciliation at discharge 1.01 (1.30) 6.3 1.73 (0.87)* 26.0 −0.64 (0.87) 5.0 −0.002 (0.74) −0.8 1.33 (0.92) 16.6 0.21 (0.59) 3.1
High-Risk Medication 0.51 (0.91) 2.4 −0.04 (0.68) −1.2 −0.81 (0.61) 12.0 0.89 (0.42)* 28.4 0.20 (0.66) 0.1 0.20 (0.45) −0.1
  1. * p < 0.10, **p < 0.05